Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT06214793
Title Taletrectinib in Previously Treated Metastatic CDH1-mutated Invasive Lobular Cancer (ILC)
Recruitment Not yet recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Megan Kruse, MD
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.